Page last updated: 2024-09-04

irofulven and Hormone-Dependent Neoplasms

irofulven has been researched along with Hormone-Dependent Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Herman, TS; MacDonald, JR; Roberts, K; Woynarowska, BA; Woynarowski, JM	1

Other Studies

1 other study(ies) available for irofulven and Hormone-Dependent Neoplasms

Article	Year
Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells. Radiation research, 2000, Volume: 154, Issue:4 Topics: Adenocarcinoma; Androgens; Antineoplastic Agents, Alkylating; Apoptosis; Combined Modality Therapy; DNA Damage; Gamma Rays; Humans; Intestinal Mucosa; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Sesquiterpenes; Tumor Cells, Cultured; Tumor Stem Cell Assay	2000

Article

Year

Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.

Radiation research, 2000, Volume: 154, Issue:4

Topics: Adenocarcinoma; Androgens; Antineoplastic Agents, Alkylating; Apoptosis; Combined Modality Therapy; DNA Damage; Gamma Rays; Humans; Intestinal Mucosa; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Sesquiterpenes; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000